<p>Carisma Therapeutics Inc. has filed to deregister its common stock, which has a par value of $0.001 per share. The company submitted the necessary documentation to terminate the registration of its securities, effectively ending its reporting obligations as a public company. As of the filing date, Carisma Therapeutics had approximately 36 holders of record for its common stock. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carisma Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-124513), on December 29, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

CARM

<p>Carisma Therapeutics Inc. has filed to deregister its common stock, terminating its reporting obligations as a public company. The company had approximately 36 holders of record for its common stock as of the filing date.</p>

Carisma Therapeutics Delists Common Stock